17-607 Phase I
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors (View details on clinicaltrial.gov)
Search Cancer Clinical Trials
The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
17 results
16-456 Phase I
A Phase 1 Study of an ERK1/2 Inhibitor (LY3214996) Administered Alone or in Combination with Other Agents in Advanced Cancer (View details on clinicaltrial.gov)
17-288 Phase I
A Phase 1/1b first-in-human dose escalation and expansion study for the evaluation of safety, pharmacokinetics, pharmacodynamics and anti-tumor activity of SAR439459 administered intravenously as monotherapy and in combination with REGN2810 in adult patients with advanced solid tumors (View details on clinicaltrial.gov)
19-318 Phase II
A Phase 1B/2 Open Label, Dose Escalation and Expansion Study of the Glutaminase inhibitor CB-839 in combination with the PARP inhibitor Talazoparib in Patients with Advanced or Metastatic Solid Tumors (View details on clinicaltrial.gov)
18-638 Phase II
A Phase 1b/2 Study of FT-2102 in Patients with Advanced Solid Tumors and Gliomas with an IDH1 Mutation (View details on clinicaltrial.gov)
14-166 Phase II
A Phase 2 Clinical Trial of Nivolumab and Nivolumab Plus Ipilimumab in Recurrent and Metastatic Microsatellite High (MSI-H) Colon Cancer (View details on clinicaltrial.gov)
18-144 Phase II
A Phase 2 Study of Dabrafenib and Trametinib in Combination with PDR001 in patients with BRAFV600E metastatic colorectal cancer (View details on clinicaltrial.gov)
17-137 Phase I
A Phase I Dose Escalation Study, with Cohort Expansion, to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of AbGn-107 Therapy in Patients with Chemo-refractory Locally Advanced, Recurrent, or Metastatic Gastric, Colorectal, or Pancreatic Cancer. (View details on clinicaltrial.gov)
18-626 Phase II
A Phase I, First-in-Human, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 510 in Subjects with Advanced Solid Tumors with a Specific KRAS Mutation (View details on clinicaltrial.gov)
18-274 Phase II
A Phase II Study of M6620 (VX-970) in Selected Solid Tumors (View details on clinicaltrial.gov)
Showing 1 - 10 of 17 results